Alibaba's AI cancer detection tool clears FDA hurdle for faster approval process
Alibaba owns the South China Morning Post. Alibaba first revealed Damo Panda, which is designed to identify pancreatic cancer, in November 2023 in a ...
Read the original at scmp.com ↗
- Topics
- China & GeopoliticsHealthcare
- Mentions
- AlibabaChinaFDA
- Tracked via
- “chinese ai”